The Abu Dhabi Investment Office (ADIO), which is state-backed, is expanding its operations in the United States to secure additional funding for the local health sector. This expansion aims to enhance Abu Dhabi’s capabilities in clinical validation and regulatory advancement, as reported by the state-run Wam news agency.

The San Francisco office will focus on the recently launched health, endurance, longevity, and medicine (Helm) cluster. This initiative is projected to contribute AED94 billion (approximately $26 billion) to Abu Dhabi’s GDP over the next two decades and is expected to create around 30 000 new jobs.

According to Mansoor Ibrahim Al Mansoori, chairman of the Department of Health in Abu Dhabi, the expanded San Francisco office will enable health innovators and entrepreneurs to collaborate with Abu Dhabi in developing and testing new solutions. This move is part of a broader strategy to tap into global healthcare opportunities.